1
Optimizing the Discovery 8c Development Interface to Improve Productivity Enhance Safety & Efficacy I Develop New Business | Explore New Markets I J 1 OthAnniversarij SlfewiSCOVERY \*4m TECHNOLOGY &f Development ® Keynote Sessions Lester M. Crawford, D.V.M., Ph.D. Acting Commissioner, FDA John L. LaMattina, Ph.D. President, Pfizer Global R&D Keynote Panel Discussion Exploring the Industry and Regulatory Interface in Drug Development Moderator: Robert R. Ruffolo, Jr., Ph.D. President, R&D, Wyeth The Boston Convention & Exhibition Center, Boston, MA Conference: August 8-11,2005 Exhibition: August 9-11,2005 For more information and to register, visit www.drugdisc.com Presidential Sponsors: as Supporting Publications: DRUG DISCOVERY TODAY MDL Executive Sponsor: Science CHEMICAL UAAAN INGENUITY' S Y S T E M S BioTechniQues" Assocation Sponsor: Organized by:

10th Anniversary DRUG DISCOVERY TECHNOLOGY & Development

  • Upload
    dinhnhi

  • View
    214

  • Download
    1

Embed Size (px)

Citation preview

Optimizing the Discovery 8c Development Interface to Improve Productivity

Enhance Safety & Efficacy I

Develop New Business |

Explore New Markets I

J

1 OthAnniversarij

SlfewiSCOVERY \*4m TECHNOLOGY

&f Development

®

Keynote Sessions Lester M. Crawford, D.V.M., Ph.D. Acting Commissioner, FDA

John L. LaMattina, Ph.D. President, Pfizer Global R&D

Keynote Panel Discussion Exploring the Industry and Regulatory Interface in Drug Development Moderator:

Robert R. Ruffolo, Jr., Ph.D. President, R&D, Wyeth

The Boston Convention & Exhibition Center, Boston, MA

Conference: August 8-11,2005

Exhibition: August 9-11,2005

For more information and to register,

visit www.drugdisc.com

Presidential Sponsors: as Supporting Publications: DRUG DISCOVERY

TODAY MDL

Executive Sponsor: Science CHEMICAL

UAAAN

INGENUITY' S Y S T E M S

BioTechniQues"

Assocation Sponsor: Organized by: